FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2921169442> ?p ?o ?g. }

• W2921169442 abstract "Abstract The efficacy of trastuzumab emtansine (T-DM1) is prolonged for some patients; however, the predictive factors remain unknown. We focused on a peripheral blood biomarker, the neutrophil-to-lymphocyte ratio (NLR), regarding T-DM1 treatment efficacy. Fifty-three advanced or metastatic breast cancers treated with T-DM1 were retrospectively recruited from three institutes. The NLR in the peripheral blood was measured at baseline and after one cycle. The cutoff value of the NLR was set at median value 2.56. The progression-free survival (PFS) of patients with NLR-low at baseline (n = 26; median, not reached) was significantly better than that of patients with NLR-high (n = 27; median, 4.13 months; hazard ratio [HR], 0.226; 95% confidence interval [CI], 0.112–0.493; p = 0.0001). Longer overall survival was significantly associated with a low NLR (HR, 0.384; 95% CI, 0.170–0.910; p = 0.0296). In the subgroup analysis, patients with NLR-low consistently had longer PFS compared to those with NLR-high irrespective of the number of prior chemotherapy regimens, prior trastuzumab, visceral metastasis, estrogen receptor status, and human epidermal growth factor receptor 2 (HER2) score. Although detailed mechanisms remain unknown, treatment efficacy of T-DM1 may be partly mediated by activation of the immune system. Low baseline NLR appears to be beneficial for treatment with T-DM1 in HER2-positive breast cancers." @default.
• W2921169442 created "2019-03-22" @default.
• W2921169442 creator A5002133447 @default.
• W2921169442 creator A5006947054 @default.
• W2921169442 creator A5007655947 @default.
• W2921169442 creator A5009382511 @default.
• W2921169442 creator A5015348662 @default.
• W2921169442 creator A5043487782 @default.
• W2921169442 creator A5055151557 @default.
• W2921169442 creator A5061516541 @default.
• W2921169442 creator A5071189878 @default.
• W2921169442 creator A5077882995 @default.
• W2921169442 date "2019-02-12" @default.
• W2921169442 modified "2023-10-02" @default.
• W2921169442 title "Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine" @default.
• W2921169442 cites W1476833121 @default.
• W2921169442 cites W1586470106 @default.
• W2921169442 cites W1841839849 @default.
• W2921169442 cites W1963151402 @default.
• W2921169442 cites W1984007340 @default.
• W2921169442 cites W2070618028 @default.
• W2921169442 cites W2076668534 @default.
• W2921169442 cites W2101979288 @default.
• W2921169442 cites W2120627364 @default.
• W2921169442 cites W2125401809 @default.
• W2921169442 cites W2128413110 @default.
• W2921169442 cites W2130900820 @default.
• W2921169442 cites W2144433586 @default.
• W2921169442 cites W2159967578 @default.
• W2921169442 cites W2164664027 @default.
• W2921169442 cites W2171778498 @default.
• W2921169442 cites W2173303337 @default.
• W2921169442 cites W2220756562 @default.
• W2921169442 cites W2286693725 @default.
• W2921169442 cites W2396716940 @default.
• W2921169442 cites W2475548831 @default.
• W2921169442 cites W2515477177 @default.
• W2921169442 cites W2559858344 @default.
• W2921169442 cites W2560361337 @default.
• W2921169442 cites W2571423414 @default.
• W2921169442 cites W2614773797 @default.
• W2921169442 cites W2621280624 @default.
• W2921169442 cites W2724741142 @default.
• W2921169442 cites W2751382700 @default.
• W2921169442 cites W2765800970 @default.
• W2921169442 cites W2767269010 @default.
• W2921169442 cites W2791284451 @default.
• W2921169442 cites W2801597117 @default.
• W2921169442 cites W2806428922 @default.
• W2921169442 cites W2884764327 @default.
• W2921169442 cites W2889281172 @default.
• W2921169442 cites W2892951532 @default.
• W2921169442 doi "https://doi.org/10.1038/s41598-018-37633-0" @default.
• W2921169442 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6372578" @default.
• W2921169442 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30755651" @default.
• W2921169442 hasPublicationYear "2019" @default.
• W2921169442 type Work @default.
• W2921169442 sameAs 2921169442 @default.
• W2921169442 citedByCount "17" @default.
• W2921169442 countsByYear W29211694422019 @default.
• W2921169442 countsByYear W29211694422020 @default.
• W2921169442 countsByYear W29211694422021 @default.
• W2921169442 countsByYear W29211694422022 @default.
• W2921169442 countsByYear W29211694422023 @default.
• W2921169442 crossrefType "journal-article" @default.
• W2921169442 hasAuthorship W2921169442A5002133447 @default.
• W2921169442 hasAuthorship W2921169442A5006947054 @default.
• W2921169442 hasAuthorship W2921169442A5007655947 @default.
• W2921169442 hasAuthorship W2921169442A5009382511 @default.
• W2921169442 hasAuthorship W2921169442A5015348662 @default.
• W2921169442 hasAuthorship W2921169442A5043487782 @default.
• W2921169442 hasAuthorship W2921169442A5055151557 @default.
• W2921169442 hasAuthorship W2921169442A5061516541 @default.
• W2921169442 hasAuthorship W2921169442A5071189878 @default.
• W2921169442 hasAuthorship W2921169442A5077882995 @default.
• W2921169442 hasBestOaLocation W29211694421 @default.
• W2921169442 hasConcept C121608353 @default.
• W2921169442 hasConcept C126322002 @default.
• W2921169442 hasConcept C143998085 @default.
• W2921169442 hasConcept C185592680 @default.
• W2921169442 hasConcept C207103383 @default.
• W2921169442 hasConcept C2775930923 @default.
• W2921169442 hasConcept C2776694085 @default.
• W2921169442 hasConcept C2778087150 @default.
• W2921169442 hasConcept C2779786085 @default.
• W2921169442 hasConcept C2781197716 @default.
• W2921169442 hasConcept C44249647 @default.
• W2921169442 hasConcept C530470458 @default.
• W2921169442 hasConcept C55493867 @default.
• W2921169442 hasConcept C71924100 @default.
• W2921169442 hasConcept C90924648 @default.
• W2921169442 hasConceptScore W2921169442C121608353 @default.
• W2921169442 hasConceptScore W2921169442C126322002 @default.
• W2921169442 hasConceptScore W2921169442C143998085 @default.
• W2921169442 hasConceptScore W2921169442C185592680 @default.
• W2921169442 hasConceptScore W2921169442C207103383 @default.
• W2921169442 hasConceptScore W2921169442C2775930923 @default.
• W2921169442 hasConceptScore W2921169442C2776694085 @default.
• W2921169442 hasConceptScore W2921169442C2778087150 @default.
• W2921169442 hasConceptScore W2921169442C2779786085 @default.

• next